Abstract

Phospholipase iPLA2β acts as a guardian against ferroptosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.
Masato Asanuma ... Norio Ogawa
Acta Medica Okayama | VOL. 58
Masato Asanuma, et. al.Masato Asanuma ... Norio Ogawa
01 Oct 2004
2021 Workshop: Neurodegenerative Diseases in the Gut-Brain Axis—Parkinson's Disease
Gary M Mawe ... John W Wiley
Gastroenterology | VOL. 162
Gary M Mawe, et. al.Gary M Mawe ... John W Wiley
08 Feb 2022
Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.
Eileen Ruth S Torres ... Charles K Meshul
Frontiers in Behavioural Neuroscience | VOL. 12
Eileen Ruth S Torres, et. al.Eileen Ruth S Torres ... Charles K Meshul
18 Jul 2018
Inflammation-associated peripheral blood cells and serum lipid levels are associated with Parkinson's disease.
Hong Jin ... Chunfeng Liu
Chinese Medical Journal | VOL. 136
Hong Jin, et. al.Hong Jin ... Chunfeng Liu
05 Mar 2023
View more papers

More From: Cancer Communications

Paper Title
Journal
Date
Author
Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma.
Sangyeop Hyun ... Daechan Park
Cancer Communications | VOL. -
Sangyeop Hyun, et. al.Sangyeop Hyun ... Daechan Park
10 Jul 2024
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.
Michael Schnekenburger ... Marc Diederich
Cancer Communications | VOL. -
Michael Schnekenburger, et. al.Michael Schnekenburger ... Marc Diederich
08 Jul 2024
Boron neutron capture therapy of cancer: where do we stand now?
Rolf F Barth ... Nilendu Gupta
Cancer Communications | VOL. -
Rolf F Barth, et. al.Rolf F Barth ... Nilendu Gupta
08 Jul 2024
SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study.
Shuqui Qin ... Xiaofeng Li
Cancer Communications | VOL. -
Shuqui Qin, et. al.Shuqui Qin ... Xiaofeng Li
08 Jul 2024
View more papers